Ustekinumab biosimilar (Curateq Biologics)

N/A

Report date: 2024/09/13 17:51:23

Base Information

Drug NameUstekinumab biosimilar (Curateq Biologics)
Drug Alias NameBP38BP-38
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Biosimilar
Mechanisms of ActionInterleukin-23 inhibitorsInterleukin-12 inhibitors
TargetsInterleukin-23Interleukin-12
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCuraTeQ Biologics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCuraTeQ Biologics Pvt Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A